Wall Street Analysts Goldman Sachs predicts that the oral GLP-1s (including oral Wegovy, Lillys orforglipron, and other pipeline products) will capture only a combined 24% of the GLP-1 market by 2030
The formula is straightforward: Concentration (mg/mL) = Total mg in vial Total mL of BAC water added Dose volume (mL) = Target dose (mg) Concentration (mg/mL) The most common approach is adding 2 mL of BAC water, which produces easy-to-measure concentrations
The problem with that model isn't the medications themselves it's everything missing around them: Every new patient pursuing GLP-1 therapy at our Grand Prairie clinic completes a full medical intake, baseline lab work, and a one-on-one consultation with Paris, our lead consultant and weight loss coach
GLP1 Muscle Loss Summary Infographic: First, Let's Address the Legitimate Concern The worry about muscle loss with GLP-1 medications is not coming from nowhere
Strength training is essential
The medical community uses glucagon-like peptide-1 (GLP-1) as a treatment for type 2 diabetes because it helps to control blood sugar levels [3]